IGF1 and breast cancer: By directly interacting with the 3′-UTR of insulin-like growth factor 1 (IGF1) mRNA, tRF-33 was identified to lead to the downregulation of IGF1 mRNA expression and protein synthesis, eventually disrupting mitochondrial homeostasis and contributing to the progression of BC pathogenesis [78].